Ahmed Awais, McHenry Nicole, Gulati Shivani, Shah Ishani, Sheth Sunil G
Department of Medicine, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Rabb 423, Boston, MA 02215, USA.
Department of Internal Medicine, Division of Gastroenterology, University of Utah Hospital, 50 N Medical Drive, Salt Lake City, UT 84132, USA.
J Clin Med. 2023 Jul 31;12(15):5030. doi: 10.3390/jcm12155030.
Disparities in pain control have been extensively studied in the hospital setting, but less is known regarding the racial/ethnic disparities in opioid prescriptions for patients with abdominal pain in ambulatory clinics.
We examined opioid prescriptions during visits by patients presenting with abdominal pain between the years of 2006 and 2015, respectively, in the National Ambulatory Medical Care Survey database. Data weights for national-level estimates were applied.
We identified 4006 outpatient visits, equivalent to 114 million weighted visits. Rates of opioid use was highest among non-Hispanic White patients (12%), and then non-Hispanic Black patients (11%), and was the lowest in Hispanic patients (6%). Hispanic patients had lower odds of receiving opioid prescriptions compared to non-Hispanic White patients (OR = 0.49; 95% CI, 0.31-0.77, = 0.002) and all non-Hispanic patients (OR 0.48; 95% CI 0.30-0.75; = 0.002). No significant differences were noted in non-opioid analgesia prescriptions ( = 0.507). A higher frequency of anti-depressants/anti-psychotic prescriptions and alcohol use was recorded amongst the non-Hispanic patients ( = 0.027 and = 0.001, respectively).
Rates of opioid prescriptions for abdominal pain patients were substantially lower for the Hispanic patients compared with the non-Hispanic patients, despite having a decreased rate of high-risk features, such as alcohol use and depression. The root cause of this disparity needs further research to ensure equitable access to pain management.
在医院环境中,疼痛控制方面的差异已得到广泛研究,但对于门诊诊所中腹痛患者阿片类药物处方的种族/民族差异了解较少。
我们分别在2006年至2015年期间,利用国家门诊医疗调查数据库,检查了腹痛患者就诊时的阿片类药物处方情况。应用了国家级估计的数据权重。
我们识别出4006次门诊就诊,相当于1.14亿次加权就诊。非西班牙裔白人患者的阿片类药物使用率最高(12%),其次是非西班牙裔黑人患者(11%),西班牙裔患者的使用率最低(6%)。与非西班牙裔白人患者相比,西班牙裔患者接受阿片类药物处方的几率较低(OR = 0.49;95% CI,0.31 - 0.77,P = 0.002),与所有非西班牙裔患者相比也是如此(OR 0.48;95% CI 0.30 - 0.75;P = 0.002)。在非阿片类镇痛处方方面未发现显著差异(P = 0.507)。在非西班牙裔患者中,抗抑郁药/抗精神病药处方和饮酒的频率较高(分别为P = 0.027和P = 0.001)。
尽管西班牙裔患者的高风险特征(如饮酒和抑郁)发生率较低,但与非西班牙裔患者相比,腹痛患者的阿片类药物处方率要低得多。这种差异的根本原因需要进一步研究,以确保公平获得疼痛管理。